Literature DB >> 9638789

Ubiquitin-proteasome-dependent proteolysis in skeletal muscle.

D Attaix1, E Aurousseau, L Combaret, A Kee, D Larbaud, C Rallière, B Souweine, D Taillandier, T Tilignac.   

Abstract

The ubiquitin-proteasome proteolytic pathway has recently been reported to be of major importance in the breakdown of skeletal muscle proteins. The first step in this pathway is the covalent attachment of polyubiquitin chains to the targeted protein. Polyubiquitylated proteins are then recognized and degraded by the 26S proteasome complex. In this review, we critically analyse recent findings in the regulation of this pathway, both in animal models of muscle wasting and in some human diseases. The identification of regulatory steps of ubiquitin conjugation to protein substrates and/or of the proteolytic activities of the proteasome should lead to new concepts that can be used to manipulate muscle protein mass. Such concepts are essential for the development of anti-cachectic therapies for many clinical situations.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9638789     DOI: 10.1051/rnd:19980202

Source DB:  PubMed          Journal:  Reprod Nutr Dev        ISSN: 0926-5287


  15 in total

1.  Alterations in mRNA expression and protein products following spinal cord injury in humans.

Authors:  Maria L Urso; Yi-Wen Chen; Angus G Scrimgeour; Patrick C Lee; K Francis Lee; Priscilla M Clarkson
Journal:  J Physiol       Date:  2007-01-11       Impact factor: 5.182

2.  Alterations of proteasome activities in skeletal muscle tissue of diabetic rats.

Authors:  S Merforth; A Osmers; B Dahlmann
Journal:  Mol Biol Rep       Date:  1999-04       Impact factor: 2.316

3.  Molecular characterization of skeletal muscle atrophy in the R6/2 mouse model of Huntington's disease.

Authors:  Pengxiang She; Zhiyou Zhang; Deanna Marchionini; William C Diaz; Thomas J Jetton; Scot R Kimball; Thomas C Vary; Charles H Lang; Christopher J Lynch
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-04-19       Impact factor: 4.310

4.  Activation of Ras and the mitogen-activated protein kinase pathway promotes protein degradation in muscle cells of Caenorhabditis elegans.

Authors:  Nathaniel J Szewczyk; Brant K Peterson; Lewis A Jacobson
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

Review 5.  Biomarkers for cancer cachexia: is there also a genetic component to cachexia?

Authors:  B H L Tan; D A C Deans; R J E Skipworth; J A Ross; K C H Fearon
Journal:  Support Care Cancer       Date:  2007-12-11       Impact factor: 3.603

6.  Diet-induced obesity and insulin resistance spur tumor growth and cancer cachexia in rats bearing the Yoshida sarcoma.

Authors:  Mary Ann Honors; Kimberly P Kinzig
Journal:  Nutr Cancer       Date:  2014-06-04       Impact factor: 2.900

7.  Identification of the immunoproteasome as a novel regulator of skeletal muscle differentiation.

Authors:  Ziyou Cui; Soyun Michelle Hwang; Aldrin V Gomes
Journal:  Mol Cell Biol       Date:  2013-10-28       Impact factor: 4.272

8.  Sarcopenia and cachexia: the adaptations of negative regulators of skeletal muscle mass.

Authors:  Kunihiro Sakuma; Akihiko Yamaguchi
Journal:  J Cachexia Sarcopenia Muscle       Date:  2012-01-12       Impact factor: 12.910

9.  NF-kappaB mediates proteolysis-inducing factor induced protein degradation and expression of the ubiquitin-proteasome system in skeletal muscle.

Authors:  S M Wyke; M J Tisdale
Journal:  Br J Cancer       Date:  2005-02-28       Impact factor: 7.640

Review 10.  Roles and potential therapeutic targets of the ubiquitin proteasome system in muscle wasting.

Authors:  David Nury; Christine Doucet; Olivier Coux
Journal:  BMC Biochem       Date:  2007-11-22       Impact factor: 4.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.